If Americans are confused about Gruyère cheese, blame the French

Or how to start a war among trade geeks

It’s war: don’t talk about geographical indications
It’s war: don’t talk about geographical indications

By Peter Ungphakorn
POSTED JANUARY 13, 2022 | UPDATED JANUARY 29, 2022

“If you’re new to trade and want to know how to start a brawl between trade people — Simon has the answer.”

That tweet, accompanied by a riotously animated GIF of a bar fight, came from Greg Messenger, associate professor at Bristol University Law School.

“Simon” is another trade law guru, Simon Lester, whose CV includes a stint in the WTO Appellate Body Secretariat.


Let’s keep up the erosion & make all cheese terms generic!

Simon Lester

“GI Simon,” punned a third trade law guru Holger Hestermeyer of The Dickson Poon School of Law, King’s College London.

Lester had tweeted the outcome of a court case as reported on NBC News: “decades of importation, production, and sale of cheese labeled GRUYERE produced outside the Gruyère region of Switzerland and France have eroded the meaning of that term and rendered it generic.”

That quote already contains a lot that is inflammatory in trade. Lester added a couple of gallons (US, of course, 3.785411784 litres each) of gasoline to the flames: “Let’s keep up the erosion & make all cheese terms generic!”

Continue reading “If Americans are confused about Gruyère cheese, blame the French”

One to watch: Bolivia’s bid to import a Canadian COVID-19 vaccine

Multiple tests: Will Canada respond? Is the WTO system too cumbersome? Is this a better route than waiving intellectual property rights?

By Peter Ungphakorn
POSTED MAY 12, 2021 | UPDATED MAY 12, 2021

News broke late yesterday (May 11, 2021) that a Canadian company, Biolyse Pharma, had agreed to supply Bolivia with 15 million doses of Johnson & Johnson’s Janssen vaccine for COVID-19, without the patent-owner’s permission.

But the deal cannot go ahead until the Canadian government issues a “compulsory licence” for Biolyse Pharma to make the vaccine in Canada and export it to Bolivia.

Although the objective is to get a cheaper version of the vaccine to a developing country — Bolivia — a lot of the focus will be on Canada, which now holds the key.

Continue reading “One to watch: Bolivia’s bid to import a Canadian COVID-19 vaccine”